Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax AMZN Option Income Strategy ETF (AMZY) vs Pfizer Inc (PFE) Price & Performance

YieldMax AMZN Option Income Strategy ETFTrade
Pfizer IncTrade

Price performance (Past 24H)

Key statistics

YieldMax AMZN Option Income Strategy ETF vs Pfizer Inc — how do they compare? YieldMax AMZN Option Income Strategy ETF trades at $10.75, while Pfizer Inc trades at $24.26 (market cap $137.76B). The key difference: Pfizer Inc pays a 7.12% dividend while YieldMax AMZN Option Income Strategy ETF pays none, and Pfizer Inc is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.

AMZYPFE
Sector
Income / Options OverlayHealth
52-Week High
$16.61$28.56
52-Week Low
$10.26$23.29
Market Cap
$137.76B
Volume
29,869,932
Enterprise Value
$188.41B
Dividend Yield
7.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

YieldMax AMZN Option Income Strategy ETF

AMZY trades at $10.78 with no significant daily movement, showing neutral technical signals overall. The ETF maintains a consistent weekly dividend distribution strategy, though recent analyst commentary highlights concerns about NAV erosion despite high yields. Technical indicators show mixed signals with bearish moving averages but neutral oscillators, while support and resistance levels cluster tightly around $10-11.

The outlook remains cautious as the synthetic option strategy delivers high income but exposes investors to amplified downside risk. While weekly distributions provide income appeal, total returns have lagged the underlying Amazon stock, creating sustainability concerns for long-term investors seeking both income and capital appreciation.

Pfizer Inc

Pfizer (PFE) trades at $24.17, down 0.33% over the past day, with a bearish technical signal from moving averages. The company maintains solid profitability with a net income margin of 11.83% and has beaten EPS estimates in three consecutive quarters. Recent news highlights pipeline advancements in obesity and oncology, with a dividend yield supported by consistent payouts.

Outlook remains mixed; analyst consensus suggests 15% upside to the $27.71 price target, but patent cliffs and revenue normalization post-COVID pose risks. The stock presents value at a P/E of 18.45, though investor sentiment is cautious amid competitive pressures and debt levels near 30% of assets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About YieldMax AMZN Option Income Strategy ETF

AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.

Read more on AMZY

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE